Newslish
ArchiveLesson #77Health

11 June 2026 · The Guardian

Ebola Vaccine Development in Progress

Scientists are racing to develop vaccines and treatments for the Bundibugyo strain of Ebola in the DRC and Uganda, with emergency funding awarded to accelerate efforts.

Free · No ads

Pick your level

Standard version (B1-B2)

Standard: natural English

71 words · ~1 min read
The Bundibugyo strain of Ebola is spreading in the Democratic Republic of the Congo (DRC) and Uganda, and currently, there is no or available. Recently, three developers received $60 million in emergency to expedite the development of solutions. However, security issues in the DRC complicate the setup of . Researchers are eager to begin testing as soon as conditions improve, emphasizing the of the situation.

Lesson audio

Standard level

Tap to play

Narration includes the headline and summary.

Adapted from The Guardian, 4 June 2026, and rewritten at three levels by Newslish. Newslish is not affiliated with the source. Read the original.

Key vocabulary

  • vaccine

    a substance used to stimulate the production of antibodies and provide immunity against diseases.

    “The new vaccine aims to protect against the Bundibugyo strain of Ebola.”

  • treatment

    the management and care of a patient for the purpose of combating a disease.

    “Researchers are working on new treatments for Ebola.”

  • funding

    money provided for a specific purpose.

    “The vaccine developers received $60 million in emergency funding.”

  • clinical trials

    research studies that test how well new medical approaches work in people.

    “The WHO expects clinical trials to begin within months.”

  • urgency

    importance requiring swift action.

    “There is a sense of urgency in combating the Ebola outbreak.”

Quick quiz

01What strain of Ebola is currently spreading in the DRC and Uganda?

02How much emergency funding was awarded to vaccine developers?

03What organization announced the funding for vaccine development?

04What is the expected timeline for clinical trials of the rVSV Bundibugyo vaccine?

Answered 0 of 4

Discussion

What challenges do you think researchers face when developing vaccines in conflict zones?